Loading...

Login
Reset Password

NDAR provides a single access to de-identified autism research data. For permission to download data, you will need an NDAR account with approved access to NDAR or a connected repository (AGRE, IAN, or the ATP). For NDAR access, you need to be a research investigator sponsored by an NIH recognized institution with federal wide assurance. See Request Access for more information.

Warning Notice

This is a U.S. Government computer system, which may be accessed and used only for authorized Government business by authorized personnel. Unauthorized access or use of this computer system may subject violators to criminal, civil, and/or administrative action. All information on this computer system may be intercepted, recorded, read, copied, and disclosed by and to authorized personnel for official purposes, including criminal investigations. Such information includes sensitive data encrypted to comply with confidentiality and privacy requirements. Access or use of this computer system by any person, whether authorized or unauthorized, constitutes consent to these terms. There is no right of privacy in this system.

You have logged in with a temporary password. Please update your password. Passwords must contain 8 or more characters and must contain at least 3 of the following types of characters:

Subscribe to our mailing list

Mailing List(s)
Email Format

You are now leaving the National Database for Autism Research (NDAR) web site to go to:

Click on the address above if the page does not change within 10 seconds.

Disclaimer

NDAR is not responsible for the content of this external site and does not monitor other web sites for accuracy.

Selected Filters
No filters selected

The filters you have selected from various query interfaces will be stored here, in the 'Filter Cart'. The database will be queried using filters added to your 'Filter Cart', when multiple filters are defined, each will be executed using 'AND' logic, so with each filter that is applied the result set gets smaller.

From the 'Filter Cart' you can inspect each of the filters that have been defined, and you also have the option to remove filters. The 'Filter Cart' itself will display the number of filters applied along with the number of subjects that are identified by the combination of those filters. For example a GUID filter with two subjects, followed by a GUID filter for just one of those subjects would return only data for the subject that is in both GUID filters.

If you have a question about the filter cart, or underlying filters please contact the help desk at The NDA Help Desk

Description
Value Range
Notes
Data Structures with shared data
No filters have been selected
Switch User

Antidepressant Treatment History Questionnaire

athq

01

Download Definition as
Download Submission Template as
Element NameData TypeSizeRequiredDescriptionValue RangeNotesAliases
subjectkeyGUIDRequiredThe NDAR Global Unique Identifier (GUID) for research subjectNDAR*
src_subject_idString20RequiredSubject ID how it's defined in lab/projectid, subjectid, subjid
interview_dateDateRequiredDate on which the interview/genetic test/sampling/imaging was completed. MM/DD/YYYYRequired fieldvisit_date
interview_ageIntegerRequiredAge in months at the time of the interview/test/sampling/imaging.0 :: 1260Age is rounded to chronological month. If the research participant is 15-days-old at time of interview, the appropriate value would be 0 months. If the participant is 16-days-old, the value would be 1 month.
genderString20RequiredSex of the subjectM;FM = Male; F = Female
visitString50RecommendedVisit nameCharacter description of each type of visitvisit_name
siteString100RecommendedSiteStudy Sitesite_uid, siteid
dsmversString10Recommendedversion/name of assessmentform_name
date_updatedDateRecommendedDate record updatededit_date
session_idString20Recommendedsession ID/screening IDscreeningid
completedIntegerRecommendedChecks if completed0::20=No; 1=Yes; 2=Yes, losttstst
atrqtrtIntegerRecommendedTreatment during CURRENT depressive episode1;21=Yes; 2=No
medication_nameString255RecommendedName of medicationatrqdrg, name
medication_notesString1,000Recommendednotes or observations regarding medicationatrq4ao
atrq8wksIntegerRecommendedAt least 8 weeks1;21=Yes; 2=No
atrqdosIntegerRecommendedEqual to or greater than1;21=Minimum Adequate Dose; 2=Minimum Optimal Dose
atrqaugIntegerRecommendedAdded to augment or boost effect1;21=Yes; 2=No
atrqmaxIntegerRecommendedDegree of Maximum Improvement1::41=A. Less than 25% improved; 2=B. Between 25% and 49% improved; 3=C. Between 50% and 75% improved; 4=D. More than 75% improved
atrqhlpString100RecommendedOf medications selected, write the one helped most
atrqectIntegerRecommendedReceived ECT during current treatment episode1;21=Yes; 2=No
atrqvnsIntegerRecommendedDid you ever receive (VNS)1;21=Yes; 2=No
atrqdbsIntegerRecommendedDid you ever receive (DBS)1;21=Yes; 2=No
weekFloatRecommendedWeek in level/study99=week 10-week 14
srcintIntegerRecommendedReliability Source of Interview information1::5; 9991 = No confidence;2 = Low confidence;3 = Moderate confidence;4 = Strong confidence;5 = High confidence; 999 = Missing
srcptrecIntegerRecommendedReliability Source of Patient Record Information1::5; 9991 = No confidence;2 = Low confidence;3 = Moderate confidence;4 = Strong confidence;5 = High confidence; 999 = Missing
srcpharmIntegerRecommendedReliability Source of Pharmacy Information1::5; 9991 = No confidence;2 = Low confidence;3 = Moderate confidence;4 = Strong confidence;5 = High confidence; 999 = Missing
srcfamlyIntegerRecommendedReliability Source of Family Information1::5; 9991 = No confidence;2 = Low confidence;3 = Moderate confidence;4 = Strong confidence;5 = High confidence; 999 = Missing
srcphysIntegerRecommendedReliability Source of Prescribing pysician1::5; 9991 = No confidence;2 = Low confidence;3 = Moderate confidence;4 = Strong confidence;5 = High confidence; 999 = Missing
srcthrptIntegerRecommendedReliability Source of Therapist1::5; 9991 = No confidence;2 = Low confidence;3 = Moderate confidence;4 = Strong confidence;5 = High confidence; 999 = Missing
reliableIntegerRecommendedReliable1::5; 9991 = No confidence;2 = Low confidence;3 = Moderate confidence;4 = Strong confidence;5 = High confidence; 999 = Missing
visdayIntegerRecommendedNumber of days from study baseline to date of visitdate
phaseIntegerRecommendedPhase9 =follow up
epilenIntegerRecommendedLength of Episode (weeks)999=Skipped
priorectIntegerRecommendedPrior ECT999=Skipped
priortxIntegerRecommendedPrior antidepressant treatment0;1;9990= Unchecked; 1= Checked
onsetIntegerRecommendedOnset DayNumber of days from study baseline/randomisation to start date of SAEdtonset
medication_dosageFloatRecommendedDosage/quantity of medicationdose
stsd1FloatRecommendedPrescribed med start date 1stdate
stpdate1FloatRecommendedStudy med stop date1
medication_weeksIntegerRecommendedTotal weeks of medication 1totwks
moutcmIntegerRecommendedMedication outcomeoutcome
bloodlvIntegerRecommendedBlood levelbloodlvl
athgmainidIntegerRecommendedATHFMainID
cmbtrialIntegerRecommendedCombination trial0;10=No; 1=Yes
ratingIntegerRecommendedSpecific Rating-Trial1::51 = No Confidence Rating: Discrepant or clearly unreliable information regarding dose, duration, compliance, and outcome of a medication trial or number and outcome of ECT trial; 2 = Low Confidence Rating: Information is marginal: Evidence of contradictions in information or significant doubt exists �regarding dose, duration, compliance, and outcome of a medication trial or number of treatments and outcome of ECT trial; 3 = Moderate Confidence Rating: Adequate information is available but based largely on one source that appears reliable.� Areas of doubt not critical in medication or ECT resistance rating; 4 = Strong Confidence Rating: Adequate information is available from more than one reliable source without significant discrepancy regarding dose, duration, compliance, and outcome of a medication trial or number and outcome of ECT trial; 5 = High Confidence Rating: Trial dose, duration, compliance, and outcome or the number of treatments and outcome of �ECT trial confirmed by multiple sources, with excellent documentation (blood levels, medication orders), strong evidence of compliance, and outcome certain.
crtrialIntegerRecommendedConfidence rating-Trial1::51 = No Confidence Rating: Discrepant or clearly unreliable information regarding dose and duration of a medication trial or number of ECT trial; 2 = Low Confidence Rating: Information is marginal: Evidence of contradictions in information or significant doubt exists �regarding dose and duration of a medication trial or number of treatments of ECT trial; 3 = Moderate Confidence Rating: Adequate information is available but based largely on one source that appears reliable.� Areas of doubt not critical in medication or ECT resistance rating; 4 = Strong Confidence Rating: Adequate information is available from more than one reliable source without significant discrepancy regarding dose and duration of a medication trial or number of ECT trial; 5 = High Confidence Rating: Trial dose and duration or the number of treatments of �ECT trial confirmed by multiple sources, with excellent documentation (blood levels, medication orders).
crcompIntegerRecommendedConfidence rating- Compliance1::5;71 = No Confidence Rating: Discrepant or clearly unreliable information regarding compliance; 2 = Low Confidence Rating: Information is marginal: Evidence of contradictions in information or significant doubt exists �regarding compliance of a medication trial; 3 = Moderate Confidence Rating: Adequate information is available but based largely on one source that appears reliable.� Areas of doubt not critical in ECT resistance rating; 4 = Strong Confidence Rating: Adequate information is available from more than one reliable source without significant discrepancy regarding compliance of a medication trial; 5 = High Confidence Rating: Trial compliance confirmed by multiple sources, with strong evidence of compliance; 7=Refused
croutcmIntegerRecommendedConfidence rating- Outcome1::51 = No Confidence Rating: Discrepant or clearly unreliable information regarding outcome of a medication trial or outcome of ECT trial; 2 = Low Confidence Rating: Information is marginal: Evidence of contradictions in information or significant doubt exists �regarding outcome of a medication trial or outcome of ECT trial; 3 = Moderate Confidence Rating: Adequate information is available but based largely on one source that appears reliable.� Areas of doubt not critical in medication or ECT; 4 = Strong Confidence Rating: Adequate information is available from more than one reliable source without significant discrepancy regarding outcome of a medication trial or outcome of ECT trial; 5 = High Confidence Rating: Trial outcome or outcome of �ECT trial confirmed by multiple sources, with outcome certain.
athf1aIntegerRecommendedEpisode: Antidepressant: Number of trials
athf1bIntegerRecommendedEpisode: Antidepressant: Highest Confidence Rating1::51 = No Confidence Rating - Discrepant or clearly unreliable information regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 2 = Low Confidence Rating - Information is marginal; Evidence of contradictions in information or significant doubt exists regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 3 = Moderate Confidence Rating - Adequate information is available but based largely on one source that appears reliable; Areas of doubt not critical in medication or ECT resistance rating; 4 = Strong Confidence Rating - Adequate information is available from more than one reliable source without significant discrepancy regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 5 = High Confidence Rating - Trial dose, duration, and compliance and outcome or number and outcome of ECT trial confirmed by multiple sources, with excellent documentation (blood levels, medication orders); strong evidence of compliance and outcome certain
athf1cIntegerRecommendedEpisode: Antidepressant: Cumulative Confidence RatingCumulative refers to the cumulative strength of all trials rated 2 or more (Do not leave any blanks, fill in with zeros where applicable)
athf2aIntegerRecommendedEpisode: Typical Antipsychotic: Number of trials
athf2bIntegerRecommendedEpisode: Typical Antipsychotic: Highest Confidence Rating1::51 = No Confidence Rating - Discrepant or clearly unreliable information regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 2 = Low Confidence Rating - Information is marginal; Evidence of contradictions in information or significant doubt exists regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 3 = Moderate Confidence Rating - Adequate information is available but based largely on one source that appears reliable; Areas of doubt not critical in medication or ECT resistance rating; 4 = Strong Confidence Rating - Adequate information is available from more than one reliable source without significant discrepancy regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 5 = High Confidence Rating - Trial dose, duration, and compliance and outcome or number and outcome of ECT trial confirmed by multiple sources, with excellent documentation (blood levels, medication orders); strong evidence of compliance and outcome certain
athf2cIntegerRecommendedEpisode: Typical Antipsychotic: Cumulative Confidence RatingCumulative refers to the cumulative strength of all trials rated 2 or more (Do not leave any blanks, fill in with zeros where applicable)
athf3aIntegerRecommendedEpisode: Atypical Antipsychotic: Number of trials
athf3bIntegerRecommendedEpisode: Atypical Antipsychotic: Highest Confidence Rating1;21 = No Confidence Rating - Discrepant or clearly unreliable information regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 2 = Low Confidence Rating - Information is marginal; Evidence of contradictions in information or significant doubt exists regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 3 = Moderate Confidence Rating - Adequate information is available but based largely on one source that appears reliable; Areas of doubt not critical in medication or ECT resistance rating; 4 = Strong Confidence Rating - Adequate information is available from more than one reliable source without significant discrepancy regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 5 = High Confidence Rating - Trial dose, duration, and compliance and outcome or number and outcome of ECT trial confirmed by multiple sources, with excellent documentation (blood levels, medication orders); strong evidence of compliance and outcome certain
athf3cIntegerRecommendedEpisode: Atypical Antipsychotic: Cumulative Confidence RatingCumulative refers to the cumulative strength of all trials rated 2 or more (Do not leave any blanks, fill in with zeros where applicable)
athf4aIntegerRecommendedEpisode: Combination: Number of trials
athf4bIntegerRecommendedEpisode: Combination: Highest Confidence Rating1::51 = No Confidence Rating - Discrepant or clearly unreliable information regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 2 = Low Confidence Rating - Information is marginal; Evidence of contradictions in information or significant doubt exists regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 3 = Moderate Confidence Rating - Adequate information is available but based largely on one source that appears reliable; Areas of doubt not critical in medication or ECT resistance rating; 4 = Strong Confidence Rating - Adequate information is available from more than one reliable source without significant discrepancy regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 5 = High Confidence Rating - Trial dose, duration, and compliance and outcome or number and outcome of ECT trial confirmed by multiple sources, with excellent documentation (blood levels, medication orders); strong evidence of compliance and outcome certain;
athf4cIntegerRecommendedEpisode: Combination: Cumulative Confidence RatingCumulative refers to the cumulative strength of all trials rated 2 or more (Do not leave any blanks, fill in with zeros where applicable)
athf5aIntegerRecommendedEpisode: ECT: Number of trials
athf5bIntegerRecommendedEpisode: ECT: Highest Confidence Rating1::51 = No Confidence Rating - Discrepant or clearly unreliable information regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 2 = Low Confidence Rating - Information is marginal; Evidence of contradictions in information or significant doubt exists regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 3 = Moderate Confidence Rating - Adequate information is available but based largely on one source that appears reliable; Areas of doubt not critical in medication or ECT resistance rating; 4 = Strong Confidence Rating - Adequate information is available from more than one reliable source without significant discrepancy regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 5 = High Confidence Rating - Trial dose, duration, and compliance and outcome or number and outcome of ECT trial confirmed by multiple sources, with excellent documentation (blood levels, medication orders); strong evidence of compliance and outcome certain
athf5cIntegerRecommendedEpisode: ECT: Cumulative Confidence RatingCumulative refers to the cumulative strength of all trials rated 2 or more (Do not leave any blanks, fill in with zeros where applicable)
athf6aIntegerRecommendedPast 6 months: Antidepressant: Number of trials
athf6bIntegerRecommendedPast 6 months: Antidepressant: Highest Confidence Rating1::51 = No Confidence Rating - Discrepant or clearly unreliable information regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 2 = Low Confidence Rating - Information is marginal; Evidence of contradictions in information or significant doubt exists regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 3 = Moderate Confidence Rating - Adequate information is available but based largely on one source that appears reliable; Areas of doubt not critical in medication or ECT resistance rating; 4 = Strong Confidence Rating - Adequate information is available from more than one reliable source without significant discrepancy regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 5 = High Confidence Rating - Trial dose, duration, and compliance and outcome or number and outcome of ECT trial confirmed by multiple sources, with excellent documentation (blood levels, medication orders); strong evidence of compliance and outcome certain
athf6cIntegerRecommendedPast 6 months: Antidepressant: Cumulative Confidence RatingCumulative refers to the cumulative strength of all trials rated 2 or more (Do not leave any blanks, fill in with zeros where applicable)
athf7aIntegerRecommendedPast 6 months: Typical Antipsychotic: Number of trials
athf7bIntegerRecommendedPast 6 months: Typical Antipsychotic: Highest Confidence Rating0::50 = Do not leave any blanks, fill in with zeros where applicable 1 = No Confidence Rating - Discrepant or clearly unreliable information regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 2 = Low Confidence Rating - Information is marginal; Evidence of contradictions in information or significant doubt exists regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 3 = Moderate Confidence Rating - Adequate information is available but based largely on one source that appears reliable; Areas of doubt not critical in medication or ECT resistance rating; 4 = Strong Confidence Rating - Adequate information is available from more than one reliable source without significant discrepancy regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 5 = High Confidence Rating - Trial dose, duration, and compliance and outcome or number and outcome of ECT trial confirmed by multiple sources, with excellent documentation (blood levels, medication orders); strong evidence of compliance and outcome certain
athf7cIntegerRecommendedPast 6 months: Typical Antipsychotic: Cumulative Confidence RatingCumulative refers to the cumulative strength of all trials rated 2 or more (Do not leave any blanks, fill in with zeros where applicable)
athf8aIntegerRecommendedPast 6 months: Atypical Antipsychotic: Number of trials
athf8bIntegerRecommendedPast 6 months: Atypical Antipsychotic: Highest Confidence Rating0::50 = Do not leave any blanks, fill in with zeros where applicable 1 = No Confidence Rating - Discrepant or clearly unreliable information regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 2 = Low Confidence Rating - Information is marginal; Evidence of contradictions in information or significant doubt exists regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 3 = Moderate Confidence Rating - Adequate information is available but based largely on one source that appears reliable; Areas of doubt not critical in medication or ECT resistance rating; 4 = Strong Confidence Rating - Adequate information is available from more than one reliable source without significant discrepancy regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 5 = High Confidence Rating - Trial dose, duration, and compliance and outcome or number and outcome of ECT trial confirmed by multiple sources, with excellent documentation (blood levels, medication orders); strong evidence of compliance and outcome certain
athf8cIntegerRecommendedPast 6 months: Atypical Antipsychotic: Cumulative Confidence RatingCumulative refers to the cumulative strength of all trials rated 2 or more (Do not leave any blanks, fill in with zeros where applicable)
athf9aIntegerRecommendedPast 6 months: Combination: Number of trials
athf9bIntegerRecommendedPast 6 months: Combination: Highest Confidence Rating1::51 = No Confidence Rating - Discrepant or clearly unreliable information regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 2 = Low Confidence Rating - Information is marginal; Evidence of contradictions in information or significant doubt exists regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 3 = Moderate Confidence Rating - Adequate information is available but based largely on one source that appears reliable; Areas of doubt not critical in medication or ECT resistance rating; 4 = Strong Confidence Rating - Adequate information is available from more than one reliable source without significant discrepancy regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 5 = High Confidence Rating - Trial dose, duration, and compliance and outcome or number and outcome of ECT trial confirmed by multiple sources, with excellent documentation (blood levels, medication orders); strong evidence of compliance and outcome certain
athf9cIntegerRecommendedPast 6 months: Combination: Cumulative Confidence RatingCumulative refers to the cumulative strength of all trials rated 2 or more (Do not leave any blanks, fill in with zeros where applicable)
athf10aIntegerRecommendedPast 6 months: ECT: Number of trials
athf10bIntegerRecommendedPast 6 months: ECT: Highest Confidence Rating1::51 = No Confidence Rating - Discrepant or clearly unreliable information regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 2 = Low Confidence Rating - Information is marginal; Evidence of contradictions in information or significant doubt exists regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 3 = Moderate Confidence Rating - Adequate information is available but based largely on one source that appears reliable; Areas of doubt not critical in medication or ECT resistance rating; 4 = Strong Confidence Rating - Adequate information is available from more than one reliable source without significant discrepancy regarding dose, duration, or compliance and outcome of a medication trial or number and outcome of ECT trial; 5 = High Confidence Rating - Trial dose, duration, and compliance and outcome or number and outcome of ECT trial confirmed by multiple sources, with excellent documentation (blood levels, medication orders); strong evidence of compliance and outcome certain
athf10cIntegerRecommendedPast 6 months: ECT: Cumulative Confidence RatingCumulative refers to the cumulative strength of all trials rated 2 or more (Do not leave any blanks, fill in with zeros where applicable)
onsetepiIntegerRecommendedIf currently depressed: Date of onset of episodeepionsetdays
Data Structure

This page displays the data structure defined for the measure identified in the title and structure short name. The table below displays a list of data elements in this structure (also called variables) and the following information:

  • Element Name: This is the standard element name
  • Data Type: Which type of data this element is, e.g. String, Float, File location.
  • Size: If applicable, the character limit of this element
  • Required: This column displays whether the element is Required for valid submissions, Recommended for valid submissions, Conditional on other elements, or Optional
  • Description: A basic description
  • Value Range: Which values can appear validly in this element (case sensitive for strings)
  • Notes: Expanded description or notes on coding of values
  • Aliases: A list of currently supported Aliases (alternate element names)
  • For valid elements with shared data, on the far left is a Filter button you can use to view a summary of shared data for that element and apply a query filter to your Cart based on selected value ranges

At the top of this page you can also:

  • Use the search bar to filter the elements displayed. This will not filter on the Size of Required columns
  • Download a copy of this definition in CSV format
  • Download a blank CSV submission template prepopulated with the correct structure header rows ready to fill with subject records and upload

Please email the The NDA Help Desk with any questions.

Distribution for DataStructure: athq01 and Element:
Chart Help

Filters enable researchers to view the data shared in NDA before applying for access or for selecting specific data for download or NDA Study assignment. For those with access to NDA shared data, you may select specific values to be included by selecting an individual bar chart item or by selecting a range of values (e.g. interview_age) using the "Add Range" button. Note that not all elements have appropriately distinct values like comments and subjectkey and are not available for filtering. Additionally, item level detail is not always provided by the research community as indicated by the number of null values given.

Filters for multiple data elements within a structure are supported. Selections across multiple data structures will be supported in a future version of NDA.